Study demonstrates pine bark naturally reduces hay fever symptoms

June 24, 2010

An estimated 60 million people in the U.S. are affected by allergic rhinitis, commonly known as hay fever, according to the American Academy of Allergy Asthma and Immunology. Hay fever is an allergic inflammation of the nasal airways that causes itching, swelling, mucus production, hives and rashes. A study published in the June 14, 2010 issue of Phytotherapy Research demonstrates Pycnogenol® (pic-noj-en-all), an antioxidant plant extract derived from the bark of the French maritime pine tree, substantially improves the symptoms of hay fever.

"Allergic rhinitis is often mistakenly believed to be a trivial health problem, while people suffering from hay fever may disagree as they experience a dramatic impairment to their quality of life," said Dr. Malkanthi Evans Scientific Director KGK Synergize Inc., a lead researcher on the study. "This study confirmed that taking Pycnogenol® naturally relieves eye and nasal symptoms of hay-fever patients owing to lower pollen-specific antibodies, particularly for ocular and nasal distress."

In a randomized, double-blind, placebo-controlled study conducted by KGK Synergize, Inc.,60 subjects between the ages of 18 and 65 began treatment three to eight weeks prior to the onset of birch allergy season in Ontario, Canada. All subjects tested positive for birch pollen allergies, a seasonal trigger of hay fever, as determined by skin prick tests. Patients were assigned to a Pycnogenol® group or placebo group according to a computer-generated, randomized schedule. Neither the patient, the investigator nor research staff was informed to which test order the subjects were assigned. Subjects were instructed to take either one 50 mg Pycnogenol® tablet or one placebo tablet twice daily, once in the morning and once in the evening throughout the allergy season. Patients were allowed to use non-prescription antihistamines as needed and recorded usage and dosage in treatment journals. The study was approved by an ethical committee as well as the "Health Canada" authorities.

Blood was collected before and after treatment throughout the entire birch pollen season for the measurement of birch specific IgE antibodies. Upon recognition of a specific allergen the IgE class of antibodies stimulates the release of histamine, an inflammatory mediator responsible for the hay-fever symptoms. During exposure to pollen allergic people develop higher levels of the corresponding IgE antibody, which goes along with increasing hay-fever symptoms. Comparison of birch specific IgE levels from the start of the trial and the end of allergy season showed an increase of 31.9 percent in the placebo group but only 19.4 percent in the Pycnogenol® group.

Subjects were instructed to rate nasal and eye symptoms daily by means of a self-administered questionnaire, recording values in their treatment journals. These resemble problems well known to people affected by hay-fever: burning, itchy, watering or tearing eyes, redness, sneezing and stuffy, runny or itchy nose. All nasal and eye symptoms were scored with values ranging from "zero" (symptoms absent) to a maximum of "three" (severe, symptoms completely preventing normal activity). Throughout the birch pollen seasons around mid of April until end of May, the total average nasal and eye symptom score was lower in the Pycnogenol® group than in the placebo group. A detailed analysis showed that Pycnogenol® was more effective the earlier patients began taking the product prior to the onset of the exposure to birch pollen. The researchers speculate that a lag-time of at least five weeks prior to pollen exposure is required for Pycnogenol® to defy hay-fever symptoms. Subjects taking Pycnogenol® seven weeks before onset of the birch season required very little non-prescription antihistamine medication (12.5%) compared with subjects taking the placebo (50%).

"For the many people seeking alternatives to conventional treatment for allergic rhinitis Pycnogenol® may represent an effective and completely natural solution, void of any side-effects" said Evans.

Previous studies have revealed Pycnogenol® to favorably affect patients suffering from allergies. Two earlier clinical trials showed that Pycnogenol® improves symptoms and breathing ability of asthma patients. Asthma is likewise triggered by airborne allergens and Pycnogenol® was demonstrated to significantly decrease leukotriene levels, an inflammatory mediator involved in asthma and hay fever alike. Human pharmacologic studies have pointed to a general anti-inflammatory potency of Pycnogenol®.

MWW Group

---

---

	Hay Fever and Allergies: Discovering the Real Culprits and Natural Solutions for Reversing Allergic Rhinitis by Case Adams PhD (Author) Springtime is now dreaded by more people every year, and increasingly, throughout the year. Scientists and doctors are mystified by this rapid growth of allergies among the developed world - growing at nearly epidemic levels. Why are so many people suffering from allergies and hay fever - medically called allergic rhinitis - and why is the condition expanding so quickly? Furthermore, what causes allergies, and more importantly, can we do anything to reverse them? Drawing from hundreds of clinical studies and research papers along with a keen understanding of physiology and traditional medicine, the author finally uncovers the mysteries surrounding allergic rhinitis. After defining the mechanics of the condition and the range of allergens subject to sensitivities, the author unveils the...
	Allergic Rhinitis in Family Practice: The Role of Levocetirizine in Clinical Care (Postgraduate Medicine) by JTE Multimedia Abstract: Allergic rhinitis is one of the most common presentations of allergic disorders in the United States, affecting more than 20% of the population. Chronic rhinitis affects patients' quality of life and exacerbates comorbid conditions. Its widespread burden affects society by substantially decreasing worker and scholastic productivity. Allergic rhinitis is typically managed with pharmacotherapy to alleviate symptoms and control comorbid conditions, yet many of these agents carry their own burden due to bothersome and sometimes severe side effects that can compromise patient safety. A new generation of non- or less-sedating antihistamines has recently emerged. These agents offer the promise of enhanced efficacy and tolerability. Of these agents, levocetirizine is the latest...
	Risk Factors and Asthma Phenotypes in Children and Adults with Seasonal Allergic Rhinitis (The Physician and Sportsmedicine) by JTE Multimedia Background There are few data on asthma risk factors and phenotypes in patients with seasonal allergic rhinitis (SAR). Methods Thirty-three children (mean age, 8.27 ± 1.77 years) and 82 adults (mean age, 34.12 ± 10.59 years) with SAR were evaluated for asthma (history, reversibility of bronchial obstruction, increased inhaled nitric oxide). The following asthma risk factors were considered in the multiple regression analysis: male sex, family history of asthma, breastfeeding < 2 months, passive/active smoking, obesity, pets/molds exposure, high total serum immunoglobulin E (IgE), polysensitization (sensitized to 3 seasonal pollens with different structure), mixed sensitization (seasonal and perennial allergens), severe rhinitis (according to the Allergic Rhinitis and its Impact on...
	ALLERGIC RHINITIS AND RHINOSINUSITIS: Is there a connection between allergy and infection? (Postgraduate Medicine) by JTE Multimedia Each year allergic rhinitis and rhinosinusitis account for millions of office visits and billions of dollars spent on prescription and nonprescription drugs. Although the causes and symptoms of these two ailments differ, there is evidence that they are linked. The authors explain how effective control of allergy symptoms can reduce the incidence and severity of rhinosinusitis. Original Publication Date: April 1999
	Childhood Rhinitis and Sinusitis (Allergic Disease and Therapy) by C. K. Naspitz (Author) The most common ailments of children worldwide affect the upper respiratory tract: the common cold, allergies, and infection of ear, nose, throat, or sinuses; medical treatment rarely seeks the etiology except in chronic or recurrent cases. Otolaryngologists and allergists explore the untraversed te
	Fast Facts: Rhinitis by Glenis K. Scadding (Author), Wytske J. Fokkens (Author) Allergic diseases have been described as a modern epidemic, yet the majority of patients are treated by family physicians or specialists outside the fields of allergy, lung medicine or otorhinolaryngology. Written by two leading international experts, "Fast Facts: Rhinitis" provides a concise, practical guide that will be invaluable to all healthcare professionals responsible for its diagnosis and management. Contents: Introduction; Allergy: an increasing problem; Allergens; Pathogenesis; Classification of allergic rhinitis; Seasonal allergic rhinitis; Non-allergic rhinitis; Diagnosing rhinitis; Therapeutic principles; Rhinosinusitis and nasal polyps; Comorbidities and complications of allergic rhinitis; Future trends.
	Allergic And Nonallergic Rhinitis: Directing Medical Therapy At Specific Symptoms (Postgraduate Medicine) by JTE Multimedia "Allergy season" may be somewhat of a misnomer, since for some people, allergies are always in season. But for many, rhinitis and other symptoms are strongly influenced by Mother Nature and are at their worst during the annual periods of pollen overload. Dr Graft describes how to determine the cause of rhinitis, whether allergy related or not, and how to choose the most effective medication on the basis of disease severity and accompanying problems. Original Publication Date: August 1996
	Allergic Rhinitis by Niels Mygind (Author), Glenis K. Scadding (Author) Allergic diseases have been described as a modern epidemic, with allergic rhinitis the most widespread condition. Yet the majority of patients are treated by family physicians or specialists outside the fields of allergy, lung medicine or otorhinolaryngology. This text provides a concise, pracical guide that should be valuable to all healthcare professionals responsible for its diagnosis and management.
	The Allergy Detective: Allergic Rhinitis Treatments Secrets Your Doctor May Not Tell You by Integrative Medical Press Allergy cases are on the rise, and are often frustrating for lack of understanding and for lack of knowledge about how to properly treat them. Rhinitis, or inflammation of the nasal mucous membranes, can lead to postnasal drip, chronic and recurrent sinus infections, sinus pressure, headaches, and even asthma symptoms of chest tightness, shortness of breath, coughing, and wheezing. The bulk of rhinitis cases are treated by primary care health care providers, or are handled by patients who self-treat. However, many health care providers do not have a deep understanding of the biological mechanisms of rhinitis symptoms. Also, many patients who self-treat use over-the-counter medications that can actually prolong nasal symptoms — and can even pose further, more serious health...
	Acupuncture for Allergic Rhinitis (NTSC) by Li Suhe (Author)